You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mantle cell lymphomas (MCL)

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type2 Diabetes Trial in Clichy (new quantitative imaging techniques with contast products, blood sample, second generation

Recruiting
  • Type2 Diabetes
  • new quantitative imaging techniques with contast products
  • +2 more
  • Clichy, France
    Hôpital Beaujon
Mar 21, 2022

Stage IV Pancreatic Cancer Trial in United States (cixutumumab, erlotinib HCl, gemcitabine HCl)

Completed
Has Results
  • Stage IV Pancreatic Cancer
  • cixutumumab
  • +2 more
  • Jonesboro, Arkansas
  • +145 more
Jan 13, 2022

Cytomegalovirus Infections, Haematological Malignancy, Organ or Tissue Transplant; Complications Trial in Parkville (Blood

Enrolling by invitation
  • Cytomegalovirus Infections
  • +3 more
  • Blood sampling
  • Parkville, Victoria, Australia
    Royal Melbourne Hospital
Apr 28, 2022

Postconcussion Syndrome, Mild Traumatic Brain Injury Trial in Toronto (Non-pharmacological Individualized rehabilitative

Recruiting
  • Postconcussion Syndrome
  • Mild Traumatic Brain Injury
  • Non-pharmacological Individualized rehabilitative therapy
  • Non-pharmacological Usual care therapy
  • Toronto, Ontario, Canada
    Toronto Rehabilitation Institute
Oct 2, 2023

Advanced or Metastatic Esophageal Squamous Cell Cancer Without Previous Systemic Chemo Trial in Guangzhou (Toripalimab)

Active, not recruiting
  • Advanced or Metastatic Esophageal Squamous Cell Cancer Without Previous Systemic Chemotherapy
  • Toripalimab
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Aug 30, 2021

GVHD, Acute Trial in Denmark, Norway, Sweden (Decidua Stroma Cells (DSC), Best available Treatment (BAT))

Recruiting
  • GVHD, Acute
  • Decidua Stroma Cells (DSC)
  • Best available Treatment (BAT)
  • Copenhagen, Denmark
  • +5 more
Sep 30, 2021

A Open Label, Post Marketing Surveillance Study Following

Completed
  • Transfusion Related Acute Lung Injury
  • Standard of Care
  • Los Angeles, California
  • +14 more
Feb 16, 2022

NSCLC, Carcinoma, Squamous Cell, Adenocarcinoma Trial in United Kingdom (AZD4547, Vistusertib, Palbociclib)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +2 more
  • Aberdeen, United Kingdom
  • +24 more
Nov 2, 2021

Hematologic Tumors Trial in Milan (Cyclophosphamide, Hematopoietic Stem Cell Transplantation,)

Recruiting
  • Hematologic Neoplasms
  • Milan, Italy
    European Institute of Oncology
Sep 24, 2021

Advanced Solid Tumors, NSCLC Trial in Israel, United States (BAY2862789)

Not yet recruiting
  • Advanced Solid Tumors
  • Non-small Cell Lung Cancer
  • Detroit, Michigan
  • +5 more
May 5, 2023

Early Systemic Stabilization Therapy on Recent Onset Vitiligo

Completed
  • Vitiligo
    • (no location specified)
    Sep 3, 2021

    GVHD Trial in New York (Bortezomib, Cyclophosphamide)

    Active, not recruiting
    • GVHD
    • New York, New York
      New York University School of Medicine
    Apr 15, 2022

    Obesity, Abdominal Obesity, Metabolic Syndrome Trial in Surabaya (Nur Aisiyah Widjaja)

    Completed
    • Obesity
    • +6 more
    • Nur Aisiyah Widjaja
    • Surabaya, East Java, Indonesia
      Institute of Tropical Disease (ITD) Airlangga University, Campus
    Jan 6, 2023

    Corneal Findings in Patients Treated With Belantamab Mafodotin

    Not yet recruiting
    • Multiple Myeloma
    • +2 more
    • Belantamab mafodotin
    • (no location specified)
    Apr 25, 2023

    Myelodysplastic Syndrome (MDS) With Refractory Anemia (RA), Severe Aplastic Anemia (SAA) Trial run by the NHLBI (Umbilical Cord

    Completed
    Has Results
    • Myelodysplastic Syndrome (MDS) With Refractory Anemia (RA)
    • Severe Aplastic Anemia (SAA)
    • Umbilical Cord Blood
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Dec 16, 2021

    Esophageal Squamous Cell Carcinoma Trial in Nanjing (Toripalimab, Paclitaxel liposome/Carboplatin, Intensity-modulated

    Recruiting
    • Esophageal Squamous Cell Carcinoma
    • Nanjing, Jiangsu, China
      Nanjing Drum Tower Hospital
    Nov 24, 2020

    Kidney Failure, Kidney Transplant Trial in Boston (T Regulatory Cell Infusion)

    Completed
    • Kidney Failure, Kidney Transplant
    • T Regulatory Cell Infusion
    • Boston, Massachusetts
      Massachusetts General Hospital
    Nov 15, 2021

    Brain Metastases From NSCLC (NSCLC) Trial in Worldwide (NovoTTF-200M device, Best Standard of Care)

    Recruiting
    • Brain Metastases From Non-small Cell Lung Cancer (NSCLC)
    • NovoTTF-200M device
    • Best Standard of Care
    • Birmingham, Alabama
    • +109 more
    Jun 21, 2022

    T-cell Acute Lymphoblastic Leukemia, T-cell Non-Hodgkin Lymphoma Trial in Shenzhen (anti-CD5 CAR T cells)

    Recruiting
    • T-cell Acute Lymphoblastic Leukemia
    • T-cell Non-Hodgkin Lymphoma
    • anti-CD5 CAR T cells
    • Shenzhen, Guangdong, China
      Peking University Shenzhen Hospital
    Feb 27, 2021

    Cross-sectional Characterization of Idiopathic Bronchiectasis

    Completed
    • Infection
    • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 7, 2023

      Dual-target CAR-T Cells, B ALL, Relapse Trial in Shenzhen (Dual target CAR-T cell therapy)

      Unknown status
      • Dual-target CAR-T Cells
      • +3 more
      • Dual target CAR-T cell therapy
      • Shenzhen, Guangdong, China
        Shenzhen University General hospital
      Jan 23, 2021

      Curvature of Spine Trial in Chicago (Tranexamic Acid)

      Completed
      Has Results
      • Curvature of Spine
      • Tranexamic Acid
      • Chicago, Illinois
        Northwestern Memorial Hospital
      Jan 5, 2021

      Analgesia, Pain, Postoperative, Spinal Stenosis Trial in Thessaloniki (Tramadol with ropivacaine, Dexmedetomidine with

      Recruiting
      • Analgesia
      • +3 more
      • Tramadol with ropivacaine
      • +3 more
      • Thessaloniki, Greece
        AHEPA University Hospital
      Feb 14, 2022

      Lung Cancer Trial in Vejle (Day 1: Cisplatin 75 mg/m2, Day 1: Vinorelbine 25 mg/m2, Day 8: Capsule vinorelbine 50 mg/m2)

      Terminated
      • Lung Cancer
      • Day 1: Cisplatin 75 mg/m2
      • +7 more
      • Vejle, Denmark
        Department of Oncology, Vejle Hospital
      Apr 28, 2021

      Sickle Cell Disease, Thalassemia Trial in Memphis (Hydroxyurea, Hydroxyurea Oral Capsule)

      Terminated
      Has Results
      • Sickle Cell Disease
      • Thalassemia
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      Feb 18, 2022